About CorMatrix Cardiovascular, Inc. - Synthetic Royalty and Milestone Rights
Available information shows that CorMatrix Cardiovascular, Inc. - Synthetic Royalty and Milestone Rights operates in the Medical Products sector. Investors on record include Ligand Pharmaceuticals, Inc.. The company is headquartered in United States.